The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of the selective MET kinase inhibitor INC280 in advanced papillary renal cell cancer.
 
Paul Denis Leger
No Relationships to Disclose
 
Daniel da Motta Girardi
No Relationships to Disclose
 
Munjid Al Harthy
No Relationships to Disclose
 
Julia C. Friend
No Relationships to Disclose
 
Lisa Mac
No Relationships to Disclose
 
Erin Purcell
No Relationships to Disclose
 
Cathy Vocke
No Relationships to Disclose
 
Sandeep Gurram
No Relationships to Disclose
 
Maria J. Merino
No Relationships to Disclose
 
Peter Choyke
No Relationships to Disclose
 
W. Marston Linehan
No Relationships to Disclose
 
Ramaprasad Srinivasan
Research Funding - AstraZeneca (Inst); Calithera Biosciences (Inst); Peloton Therapeutics (Inst); Sanofi (Inst)